Limited uptake of 60-day scripts

Fewer than one-in-10 prescriptions for molecules eligible for double dispensing are being written for 60 days’ supply  Data from more than 4000 community pharmacies across Australia shows that over the first 13 days of the controversial 60-day dispensing policy, just 9.77% of scripts for eligible medications were for two packs of the products.  NostraData had reported

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Phenylephrine not effective
Next PBS funding for vigabatrin substitution